Similar articles

• Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization.

  Rattazzi MC, Brown JA, Davidson RG, Shows TB. Rattazzi MC, et al. Birth Defects Orig Artic Ser. 1975;11(3):232-5. Birth Defects Orig Artic Ser. 1975. PMID: 812568 No abstract available.
• Tay-Sachs and Sandhoff diseases: an hypothesis about the primary lesion based on hexosaminidase patterns in interspecific hybrids.

  Cong NV, Weil D, Rebourcet R, Pangalos C, Frézal J. Cong NV, et al. Cytogenet Cell Genet. 1975;14(3-6):442-5. doi: 10.1159/000130402. Cytogenet Cell Genet. 1975. PMID: 1192834 No abstract available.
• [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].

  Weil D, Van Cong N, Rebourcet R, Frézal J. Weil D, et al. Ann Genet. 1975 Sep;18(3):163-8. Ann Genet. 1975. PMID: 810067 French.
• Approaches to the control and prevention of Tay-Sachs disease.

  Kaback MM, Zeiger RS, Reynolds LW, Sonneborn M. Kaback MM, et al. Prog Med Genet. 1974;10:103-34. Prog Med Genet. 1974. PMID: 4620174 Review.
• Intravenous injection of purified hexosaminidase A into a patient with Tay-Sachs disease.

  Johnson WG, Desnick RJ, Long DM, Sharp HL, Krivit W, Brady B, Brady RO. Johnson WG, et al. Birth Defects Orig Artic Ser. 1973 Mar;9(2):120-4. Birth Defects Orig Artic Ser. 1973. PMID: 4611523 Review. No abstract available.